Pharmacopsychiatry
International guidelines on post-authorisation research and surveillance. European Economic Community
Abstract
Recently, post authorisation research and surveillance has become more and more important. This article investigates which common standards already exist and which methods and tools are used in this context. This paper focusses on a draft version of the "Notice to applicants for marketing authorisations for medical products for human use in the European Community" which will be mandatory for all EC member countries after its finalization.
Source and rights
Published by Pharmacopsychiatry, 1997. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 1997
- Country of origin
- 🇩🇪 Germany
- Scope
- Regional
- Journal
- Pharmacopsychiatry
- PubMed
- 9035230
- Added to Prognia
- 25 July 2026




